The Humoral Immunology Section studies the antibody response to HIV-1 and SARS-COV-2 infection or vaccination. Ongoing research focuses on antibody discovery and antibody-virus co-evolution in infected patients or non-human primate models, with the goals of providing templates for vaccine design and antibodies with potential for clinical utility in preventing or treating infection.

Humoral Immunology Core and Humoral Immunology Section: (left to right) Stephen Schmidt, Nicole Doria-Rose, Yuliya Petrova, Walker Black, John Mascola, Zenia Vrakas, Evan Cale, James DalSanto, Sabrina Bush, Colin Howe, Maryam Mukhamedova, Behnia Rezazadeh Shirazi, Rosemarie Mason, Travis Terry, Kevina Birungi, Hua Wang
Richard Koup, M.D.
Deputy Director, Vaccine Research Center
Chief, Immunology Laboratory and Immunology Section
Acting Chief, Vaccine Immunology Program
Acting Head, Tissue Analysis Core
Contact: rkoup@mail.nih.gov
Education:
M.D., 1982, Johns Hopkins University School of Medicine, Baltimore, MD
M.S., 1979, University of Connecticut, Stamford, CT
B.S., 1978, University of Connecticut, Stamford, CT

Evan Cale, Ph.D.
Staff Scientist
Contact: evan.cale@nih.gov
Education:
Ph.D., Immunology, 2011, Harvard Medical School, Boston, MA

Nicole Doria-Rose, Ph.D.
Chief, Antibody Immunity Section
Stadtman Tenure Track Investigator
Contact: doriarosen@mail.nih.gov
Education:
Ph.D., 1998, Cornell University, Ithaca, NY

Former Research Group Members
Xueling Wu, Ph.D. - Currently faculty at the Aaron Diamond AIDS Research Center at Columbia University.
Rebecca Lynch, Ph.D. - Currently faculty at George Washington University
Rui Kong, Ph.D. - Currently faculty at Emory University